🇺🇸 FDA
Patent

US 6833132

Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity

expired A61KA61K38/00A61P

Quick answer

US patent 6833132 (Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
121
CPC classes
A61K, A61K38/00, A61P, A61P17/00, A61P17/02